Amsterdam, The Netherlands, 11 May 2017

by Beurs van Berlage
World Health Organization

15 pp. 4.9 MB

The main aim of the Forum was to enable stakeholders to discuss options for a fairer pricing system that is sustainable for both health systems and the pharmaceutical industries.

The Forum sought to address three questions:

  • What can governments do to ensure fairer medicines prices and greater access?
  • What can industry do?
  • How can WHO support the process?

Key issues addressed included: developing alternative approaches for research and development (R&D) and business models for innovation; facilitating collaboration among payers by expanding current networks to include other relevant stakeholders and countries; increasing exchange of information, for example to assess the value of new products; promoting transparency of prices paid, R&D costs, production costs, and profit margins.

(Visited 9 times, 1 visits today)
This entry was posted in Development Assistance, Essential Medicines, General. Bookmark the permalink.
Facebook Auto Publish Powered By :
Get the latest issue of the NewsletterDownload